Genomics Services Market Trends and Overview
The Genomics Services Market was valued at USD 16.4 billion in 2022 and is projected to reach USD 46.4 billion by 2030, exhibiting a compound annual growth rate (CAGR) of approximately 12.8% during the forecast period from 2023 to 2030.
The market for genomics services has experienced significant growth and is expected to continue its upward trajectory in the coming years. This growth can be attributed to various factors, including advancements in technology, increasing demand for personalized medicine, and the rising prevalence of genetic disorders.
Advancements in genomics technology have revolutionized the field of healthcare and have paved the way for personalized medicine. The ability to analyze an individual's genetic makeup has opened doors to targeted therapies and treatments, leading to improved patient outcomes. As a result, there has been a surge in the demand for genomics services, driving market growth.
Furthermore, the increasing prevalence of genetic disorders has also contributed to the expansion of the genomics services market. Genetic disorders, such as cancer, cardiovascular diseases, and rare genetic conditions, have become a significant burden on healthcare systems worldwide. Genomics services play a crucial role in the diagnosis, treatment, and management of these disorders, thereby fueling market growth.
Geographically, North America currently dominates the genomics services market, owing to the presence of well-established healthcare infrastructure, technological advancements, and favorable government initiatives. However, the Asia Pacific region is expected to witness the highest growth rate during the forecast period. Factors such as a large population base, increasing healthcare expenditure, and growing awareness about genomics services are driving the market in this region.
In conclusion, the genomics services market is poised for substantial growth in the coming years. Advancements in technology, increasing demand for personalized medicine, and the rising prevalence of genetic disorders are key factors driving this growth. With the potential to transform healthcare and improve patient outcomes, genomics services are set to play a pivotal role in the future of medicine.
Get Free Sample Report @ https://www.snsinsider.com/sample-request/2873
KEY MARKET SEGMENTATION:
By Application & Deliverables
- Functional Genomics
- Pathway Analysis
- Biomarker Discovery
- Consumables & Reagents
- NGS-based Services
- Core Genomics Services
- Biomarker Translation Services
- Computational Services
By End users
- Clinical Research
- Academic & Government Institutes
- Hospitals & Clinic
- Pharmaceutical & Bio Technology Companies
- Other End Users
Major Players Listed in the Report are as Follows:
- Hoffmann-La Roche Ltd, Agilent Technologies, Thermo Fisher Scientific, Inc, Bio-Rad Laboratories, Inc, 23andMe, Inc., Illumina, Inc, Myriad Genetics, Inc., Foundation Medicine, Inc., Danaher, Pacific Biosciences, Oxford Nanopore Technologies, BGI and others.
SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.
We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.
Akash Anand – Head of Business Development & Strategy,
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND),